G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension (original) (raw)

Nature Medicine volume 14, pages 64–68 (2008)Cite this article

A Corrigendum to this article was published on 01 February 2008

This article has been updated

Abstract

The tone of vascular smooth muscle cells is a primary determinant of the total peripheral vascular resistance and hence the arterial blood pressure. Most forms of hypertension ultimately result from an increased vascular tone that leads to an elevated total peripheral resistance1,2,3. Regulation of vascular resistance under normotensive and hypertensive conditions involves multiple mediators, many of which act through G protein–coupled receptors on vascular smooth muscle cells4. Receptors that mediate vasoconstriction couple with the G-proteins Gq-G11 and G12-G13 to stimulate phosphorylation of myosin light chain (MLC) via the Ca2+/MLC kinase– and Rho/Rho kinase–mediated signaling pathways, respectively4,5,6. Using genetically altered mouse models that allow for the acute abrogation of both signaling pathways by inducible Cre/_loxP_-mediated mutagenesis in smooth muscle cells, we show that Gq-G11–mediated signaling in smooth muscle cells is required for maintenance of basal blood pressure and for the development of salt-induced hypertension. In contrast, lack of G12-G13, as well as of their major effector, the leukemia-associated Rho guanine nucleotide exchange factor (LARG), did not alter normal blood pressure regulation but did block the development of salt-induced hypertension. This identifies the G12-G13–LARG–mediated signaling pathway as a new target for antihypertensive therapies that would be expected to leave normal blood pressure regulation unaffected.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Change history

In the version of this article initially published, the name of one author was incorrectly listed as Silvio Gutkind. The correct name is J. Silvio Gutkind. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Brown, R., Mullins, J. & Webb, D.J. Mechanisms and molecular pathways in hypertension. in Molecular Basis of Cardiovascular Disease (ed. Chien, K.R.) 566–647 (Saunders, Philadelphia, 2004).
    Google Scholar
  2. Cowley, A.W., Jr. Long-term control of arterial blood pressure. Physiol. Rev. 72, 231–300 (1992).
    Article Google Scholar
  3. Lifton, R.P., Gharavi, A.G. & Geller, D.S. Molecular mechanisms of human hypertension. Cell 104, 545–556 (2001).
    Article CAS Google Scholar
  4. Maguire, J.J. & Davenport, A.P. Regulation of vascular reactivity by established and emerging GPCRs. Trends Pharmacol. Sci. 26, 448–454 (2005).
    CAS PubMed Google Scholar
  5. Gohla, A., Schultz, G. & Offermanns, S. Role for G12/G13 in agonist-induced vascular smooth muscle cell contraction. Circ. Res. 87, 221–227 (2000).
    Article CAS Google Scholar
  6. Somlyo, A.P. & Somlyo, A.V. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83, 1325–1358 (2003).
    Article CAS Google Scholar
  7. Chobanian, A.V. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206–1252 (2003).
    Article CAS Google Scholar
  8. Ezzati, M. et al. Rethinking the “diseases of affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2, e133 (2005).
    Article Google Scholar
  9. O'Shaughnessy, K.M. & Karet, F.E. Salt handling and hypertension. J. Clin. Invest. 113, 1075–1081 (2004).
    Article CAS Google Scholar
  10. Meneton, P., Jeunemaitre, X., de Wardener, H.E. & MacGregor, G.A. Links between dietary salt intake, renal salt handling, blood pressure and cardiovascular diseases. Physiol. Rev. 85, 679–715 (2005).
    Article CAS Google Scholar
  11. Iwamoto, T. et al. Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle. Nat. Med. 10, 1193–1199 (2004).
    Article CAS Google Scholar
  12. Dostanic, I. et al. The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am. J. Physiol. Heart Circ. Physiol. 288, H477–H485 (2005).
    Article CAS Google Scholar
  13. Blaustein, M.P., Zhang, J., Chen, L. & Hamilton, B.P. How does salt retention raise blood pressure? Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R514–R523 (2006).
    Article CAS Google Scholar
  14. Narumiya, S., Ishizaki, T. & Watanabe, N. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett. 410, 68–72 (1997).
    Article CAS Google Scholar
  15. Fukata, Y., Amano, M. & Kaibuchi, K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22, 32–39 (2001).
    Article CAS Google Scholar
  16. Fukuhara, S., Chikumi, H. & Gutkind, J.S. RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? Oncogene 20, 1661–1668 (2001).
    Article CAS Google Scholar
  17. Wettschureck, N. et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat. Med. 7, 1236–1240 (2001).
    Article CAS Google Scholar
  18. Moers, A. et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat. Med. 9, 1418–1422 (2003).
    Article CAS Google Scholar
  19. Indra, A.K. et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinases. Nucleic Acids Res. 27, 4324–4327 (1999).
    Article CAS Google Scholar
  20. Becknell, B. et al. Characterization of leukemia-associated Rho guanine nucleotide exchange factor (LARG) expression during murine development. Cell Tissue Res. 314, 361–366 (2003).
    Article CAS Google Scholar
  21. Moriki, N. et al. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens. Res. 27, 263–270 (2004).
    Article CAS Google Scholar
  22. Heximer, S.P. et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. 111, 445–452 (2003).
    Article CAS Google Scholar
  23. Tang, K.M. et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 9, 1506–1512 (2003).
    Article CAS Google Scholar
  24. Seasholtz, T.M. & Brown, J.H. Rho signaling in vascular diseases. Mol. Interv. 4, 348–357 (2004).
    Article CAS Google Scholar
  25. Seko, T. et al. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ. Res. 92, 411–418 (2003).
    Article CAS Google Scholar
  26. Uehata, M. et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990–994 (1997).
    Article CAS Google Scholar
  27. Amano, M., Fukata, Y. & Kaibuchi, K. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 261, 44–51 (2000).
    Article CAS Google Scholar
  28. Noma, K., Oyama, N. & Liao, J.K. Physiological role of ROCKs in the cardiovascular system. Am. J. Physiol. Cell Physiol. 290, C661–C668 (2006).
    Article CAS Google Scholar
  29. Khalil, R.A. Dietary salt and hypertension: new molecular targets add more spice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R509–R513 (2006).
    Article CAS Google Scholar
  30. Mills, P.A. et al. A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J. Appl. Physiol. 88, 1537–1544 (2000).
    Article CAS Google Scholar

Download references

Acknowledgements

The authors are grateful to M. Ritzal and T. Németh for their expert technical assistance. Z.B. and B.H. were supported by a Marie Curie Individual Fellowship and a European Molecular Biology Organization Fellowship, respectively. This work was supported by the Deutsche Forschungsgemeinschaft (Of 19/9) and the Fonds der Chemischen Industrie.

Author information

Author notes

  1. Barbara Leutgeb & Erich Greiner
    Present address: Present addresses: Solvay Arzneimittel GmbH, Hans-Böckler-Allee 20, 30173 Hannover, Germany (B.L.); EvotecOAI AG, Schnackenburgallee 114, 22525 Hamburg, Germany (E.G.).,
  2. Zoltán Benyó and Martina Lukasova: These authors contributed equally to this work.

Authors and Affiliations

  1. Institute of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, Heidelberg, 69120, Germany
    Angela Wirth, Zoltán Benyó, Martina Lukasova, Barbara Leutgeb, Nina Wettschureck, Petra Örsy, Béla Horváth, Christiane Maser-Gluth & Stefan Offermanns
  2. Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Üllöi ut 78/A, Budapest, 1082, Hungary
    Zoltán Benyó
  3. Institute of Pharmacology, Medical Faculty Mannheim, University of Heidelberg, Maybachstrasse 14, Mannheim, 68169, Germany
    Stefan Gorbey & Björn Lemmer
  4. Division of Molecular Biology of the Cell 1, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg, 69120, Germany
    Erich Greiner & Günther Schütz
  5. Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, 20892-4340, Maryland, USA
    J. Silvio Gutkind

Authors

  1. Angela Wirth
    You can also search for this author inPubMed Google Scholar
  2. Zoltán Benyó
    You can also search for this author inPubMed Google Scholar
  3. Martina Lukasova
    You can also search for this author inPubMed Google Scholar
  4. Barbara Leutgeb
    You can also search for this author inPubMed Google Scholar
  5. Nina Wettschureck
    You can also search for this author inPubMed Google Scholar
  6. Stefan Gorbey
    You can also search for this author inPubMed Google Scholar
  7. Petra Örsy
    You can also search for this author inPubMed Google Scholar
  8. Béla Horváth
    You can also search for this author inPubMed Google Scholar
  9. Christiane Maser-Gluth
    You can also search for this author inPubMed Google Scholar
  10. Erich Greiner
    You can also search for this author inPubMed Google Scholar
  11. Björn Lemmer
    You can also search for this author inPubMed Google Scholar
  12. Günther Schütz
    You can also search for this author inPubMed Google Scholar
  13. J. Silvio Gutkind
    You can also search for this author inPubMed Google Scholar
  14. Stefan Offermanns
    You can also search for this author inPubMed Google Scholar

Contributions

A.W. planned and performed most in vivo experiments, analyzed SMMHC-CreERT2 mice and was involved in writing the manuscript, Z.B. and M.L. planned and performed most in vitro experiments, B.L. helped generate and analyze SMMHC-CreERT2 mice, N.W. and S.G. helped perform in vivo experiments, P.Ö. and B.H. helped perform in vitro experiments, C.M.-G. performed DOCA level determinations, E.G. helped generate SMMHC-CreERT2 mice, B.L. helped perform in vivo experiments, G.S. helped generate SMMHC-CreERT2 mice, S.G. generated LARG-deficient mice, and S.O. planned and supervised the project and wrote the manuscript.

Corresponding author

Correspondence toStefan Offermanns.

Supplementary information

Rights and permissions

About this article

Cite this article

Wirth, A., Benyó, Z., Lukasova, M. et al. G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension.Nat Med 14, 64–68 (2008). https://doi.org/10.1038/nm1666

Download citation

This article is cited by

Associated content